Status:

RECRUITING

Effect of Bilateral Ultrasound-Guided TAP Block on Quality of Recovery in Cesarean Delivery Patients Receiving Intrathecal Morphine

Lead Sponsor:

MEHMET GÖKHAN TAFLAN

Conditions:

Postoperative Pain Management

Obstetric Anesthesia

Eligibility:

FEMALE

18-45 years

Brief Summary

This prospective, assessor-blinded observational cohort study will investigate the effect of adding bilateral ultrasound-guided transversus abdominis plane (TAP) block to standard intrathecal morphine...

Detailed Description

Effective postoperative analgesia is essential for optimizing maternal recovery after cesarean delivery, promoting early mobilization, and supporting breastfeeding initiation. Spinal anesthesia with i...

Eligibility Criteria

Inclusion

  • Female patients aged 18-45 years
  • Singleton pregnancy
  • ASA physical status II-III
  • Scheduled elective lower segment cesarean delivery under spinal anesthesia with intrathecal morphine (ITM) as standard care
  • Able to understand study procedures, provide written informed consent, and reliably use IV PCA
  • Able to complete ObsQoR-10-T assessments (with trained assistance if needed)

Exclusion

  • Contraindication to spinal anesthesia or TAP block (e.g., infection at injection site, coagulopathy, allergy to local anesthetics)
  • Chronic opioid use or opioid/alfa-2 agonist intolerance
  • Severe preeclampsia, HELLP syndrome, significant hepatic or renal impairment
  • Urgent or emergent cesarean section (Category 1)
  • Cognitive impairment or communication difficulty preventing accurate assessment
  • Prior major abdominal surgery (other than previous cesarean delivery)
  • Body mass index (BMI) \> 40 kg/m²
  • Major psychiatric illness (e.g., major depressive disorder, generalized anxiety disorder, psychosis) that may affect pain perception or quality of recovery

Key Trial Info

Start Date :

September 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 25 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT07145619

Start Date

September 1 2025

End Date

February 25 2026

Last Update

December 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samsun University Training and Research Hospital

Samsun, Samsun, Turkey (Türkiye), 55090